Cezarius oral solution 100 mg/ml

Indications

CEZARIUS is indicated as monotherapy for partial onset seizures or partial secondary generalised seizures in patients of 16 and more years of age with newly diagnosed epilepsy. CEZARIUS is indicated as an adjuvant therapy in the treatment of: – partial onset seizures or partial secondary generalised seizures in adults, children and infants of 1 month and more years of age suffering from epilepsy; – myoclonic seizures in adults and youth of 12 and more years of age and more suffering from juvenile myoclonic epilepsy; – primary generalised tonic-clonic seizure in adults and youth of 12 and more years of age and more suffering from idiopathic generalised epilepsy.